Latest stories on BRTX
BioRestorative Therapies Faces Disputed Executive Resignation Claim
TipRanks42 · neutralgeneral
BioRestorative Therapies, Inc. (BRTX) files 8-K
SEC 8-K50 · neutralgeneral
8-K/A - BioRestorative Therapies, Inc. (BRTX) files 8-K
SEC 8-K50 · neutralgeneral
BioRestorative Therapies Inc trading halted, news pending
The Fly50 · neutralgeneral
BioRestorative Therapies announces 1-for-20 reverse stock split
The Fly25 · bearishgeneral
BioRestorative Therapies, Inc. (BRTX) files 8-K
SEC 8-K50 · neutralgeneral
BioRestorative Therapies Announces Reverse Stock Split
GlobeNewswire25 · bearishgeneral
BioRestorative Therapies Announces Reverse Stock Split
StockTitan25 · bearishgeneral
BioRestorative Therapies Announces Leadership and Governance Restructuring
TipRanks50 · neutralgeneral
BioRestorative Therapies, Inc. (BRTX) files 8-K
SEC 8-K50 · neutralgeneral
BioRestorative Therapies, Inc. (BRTX) files 8-K
SEC 8-K50 · neutralgeneral
BioRestorative Therapies Delays Quarterly SEC Filing
TipRanks38 · neutralgeneral
BioRestorative Therapies Halts ExoCR and BioX Shipments
TipRanks32 · bearishgeneral
BioRestorative Therapies, Inc. (BRTX) files 8-K
SEC 8-K50 · neutralgeneral
BioRestorative Therapies Overhauls Leadership and Board Governance
TipRanks50 · neutralgeneral
BioRestorative Therapies, Inc. (BRTX) files 8-K
SEC 8-K50 · neutralgeneral
BioRestorative Revamps Board Following New Loan Agreement
TipRanks50 · neutralgeneral
BioRestorative Therapies Finalizes Executive Agreement with R&D VP
TipRanks55 · neutralgeneral
BioRestorative Therapies, Inc. (BRTX) files 8-K
SEC 8-K50 · neutralgeneral
BioRestorative Marks Major Milestone: BRTX-100 Phase 2 Dosing Complete, Eyes Topline Data in 2027
MarketChameleon67 · bullishproduct/pr
BRTX-100 Phase 2 Dosing Complete: BioRestorative Advances Regenerative Spine Therapy with FDA Fast Track Status
MarketChameleon67 · bullishproduct/pr
Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX)
PR Newswire56 · neutralm&a